Task: Answer the multiple choice question.
Question: Which compound exhibits a -0.132\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a Cc1c(Cl)c([N+](=O)[O-])nn1CCCC(=O)Nc1cccc(Cl)c1
b Cc1ccc(S(=O)(=O)N=S(CC2CC2(Cl)Cl)CC2CC2(Cl)Cl)cc1
Answer: b. Cc1ccc(S(=O)(=O)N=S(CC2CC2(Cl)Cl)CC2CC2(Cl)Cl)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(S(=O)(=O)N=S(CC2CC2(Cl)Cl)CC2CC2(Cl)Cl)cc1
Cc1ccc(S(=O)(=O)N=S(CC2CC2(Cl)Cl)CC2CC2(Cl)Cl)cc1
N-[bis[(2,2-dichlorocyclopropyl)methyl]-λ4-sulfanylidene]-4-methylbenzenesulfonamide